Clinical trial
Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for…
NCT00300027 · Bristol-Myers Squibb, Industry · Terminated
Key facts
| NCT number | NCT00300027 |
|---|---|
| Title | Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies |
| Official title | A Phase I Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of BMS-582664 in Combination With 5-Fluorouracil/Leucovorin and Irinotecan or Oxaliplatin for Patients With Advanced or Metastatic Cancer |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Gastrointestinal Neoplasms |
| Intervention type | Drug |
| Interventions | BMS-582664 |
| Enrollment | 50 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2006 |
| First posted | Mar 8, 2006 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: